FDA Warns Migraine Patch May Cause Burns and Scarring

According to the Food and Drug Administration a small battery powered device, which is meant to help those suffering from migraine headaches, may in fact have side effects which include leaving severe burns and scars on users.

The FDA is investigating reports that the patches, sold under the name Zecuity, may cause not only serious burns but also allergic reactions in some users, which can result in their developing blisters.  The battery power patch is used by migraine sufferers and administers the drug Sumatriptan through the skin.

In a statement issued by the FDA the agency acknowledged that a large number of patients have experienced burns, and even scars, in the area of the body where the patches have been worn, resulting in pain, redness, cracked skin, and blistering.  The single use product is normally worn around either the arm or the thigh, and is supposed to be taken off after 4 hours of use.  The FDA says it is investigating what it calls “serious side effects “, and will keep the public updated as to its findings.

In the meantime, the FDA suggest that anyone using the Zecuity patch, and who experiences moderate to severe pain, should immediately remove the device in order to avoid possible burns or scarring.  Such users should contact their health care providers and avoid any contact with water while wearing the patches, including bathing, showering, or swimming while wearing the device.

The Zecuity patch is relatively new to the market, having been introduced under a year ago.  As is common with many prescription drugs the manufacturer of the Zecuity patch warns of relatively mild potential side effects including tangling, inching, warmth, a change in skin color, and pain.

Migraine headaches are different from run-of-the-mill headaches in that they are usually stronger, last longer, and are not easily treatable by such over the counter medications as Advil and Tylenol.  Those suffering from migraines may require stronger prescription solutions, which work directly on the blood vessels in the brain.